December 31, 2013

IN RE ACTOS END PAYOR ANTITRUST LITIGATION

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 23, 2018

    Takeda Tries Again To Shake Actos Antitrust Claims

    Takeda Pharmaceutical Co. told a New York federal judge Tuesday that it’s common practice for drugmakers to draw loose connections between their products and their intellectual property in a national register of government-approved drugs, arguing that an antitrust lawsuit allegedly painting that list as scripture should be dismissed for a second time.

6 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS